ShlomoAKoyfmanMD
Radiation Oncology • Cleveland, OHHead & Neck, Skin Cancer
Associate Professor, Medicine, Cleveland Clinic Lerner College of Medicine
Dr. Koyfman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
# Radiatio
Cleveland, OH 44195Phone+1 216-444-1941Fax+1 216-445-1068
Education & Training
Cleveland Clinic FoundationResidency, Radiation Oncology, 2006 - 2011
Yale School of MedicineClass of 2006
Certifications & Licensure
OH State Medical License 2006 - 2026- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck Start of enrollment: 2017 May 10
Publications & Presentations
PubMed
- 7 citationsLimited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer.Zachary S Mayo, Evelyn O Ilori, Brian Matia, Timothy D Smile, Christopher W Fleming
Anticancer Research. 2022-04-01 - 3 citationsRisk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.Shannon S Wu, Nikhil Joshi, Jonathan Sharrett, Sanjay Rao, Akeesha Shah
JAMA Otolaryngology-- Head & Neck Surgery. 2023-01-01 - 470 citationsDevelopment and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICO...Brian O'Sullivan, Shao Hui Huang, Jie Su, Adam S. Garden, Erich M. Sturgis
The Lancet. Oncology. 2016-04-01
Journal Articles
- Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and ToxicityBrian B Burkey, Neil M Woody, John F Greskovich, David J Adelstein, Aditya Juloori, Shlomo A Koyfman, Joseph Scharpf, Brandon Prendes, Anticancer Research
Lectures
- Preliminary safety results of a phase II study investigating pembrolizumab in combination with postoperative intensity modulated radiotherapy (IMRT) in resected high r...2019 ASCO Annual Meeting - 6/1/2019
- Nodal Disease in HPV-Positive and HPV-Negative Cancer: Who Needs Postoperative Radiation?2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Press Mentions
When to Pursue More Aggressive Treatment for Patients with T1-2a Cutaneous Squamous Cell CarcinomaOctober 3rd, 2024- A Call for More Interdisciplinary and Preventive Care in New Osteoradionecrosis GuidelinesJuly 8th, 2024
- New Imaging Score May Predict Chemo Benefit in Early OPSCCJanuary 27th, 2023
- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Head & Neck Cancer, American College of Radiology 2015 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
